A critical discovery in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This vital cancer suppressor protein is frequently disabled in several kinds of tumors, leading https://gogogobookmarks.com/story21982873/vhh-fragments-reactivate-the-p53-protein-a-potential-approach-for-tumor-management